Opioid Dependence Drug Gets Okay for New Delivery Mode

by pgh on July 1, 2012

WASHINGTON (MedPage Today) — The FDA has approved a new sublingual film formulation of the opioid dependence treatment combination buprenorphrine/naloxone (Suboxone). (Source: MedPage Today Public Health)

Previous post: The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers

Next post: Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program: A Randomized Trial.

Copyright 2011 Oxycontin Treatment Directory | Oxycontin Treatment Directory | All About Suboxone | About | Disclaimer | Privacy Policy Built On The Thesis Theme for WordPress

WordPress Admin

Discuss Treatment

Call 877-841-0678

X